2023
DOI: 10.1016/j.apsb.2023.05.022
|View full text |Cite
|
Sign up to set email alerts
|

Towards understandings of serine/arginine-rich splicing factors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(7 citation statements)
references
References 253 publications
0
5
0
Order By: Relevance
“…This strategy has proven effective in repairing the coding sequence of the DMD causative gene in animal models [72] and also provides a new method for MSTN gene knockout in pigs [73]. An interesting observation in our study is that, consistent with the majority of alternative splicing classifications [2,74,75], we divided AS events into five types. However, in some analyses, AS events were categorized into seven classes, including an additional two events: alternative first exon (AF) and alternative last exon (AL) events [76][77][78][79].…”
Section: Discussionmentioning
confidence: 77%
“…This strategy has proven effective in repairing the coding sequence of the DMD causative gene in animal models [72] and also provides a new method for MSTN gene knockout in pigs [73]. An interesting observation in our study is that, consistent with the majority of alternative splicing classifications [2,74,75], we divided AS events into five types. However, in some analyses, AS events were categorized into seven classes, including an additional two events: alternative first exon (AF) and alternative last exon (AL) events [76][77][78][79].…”
Section: Discussionmentioning
confidence: 77%
“…Efforts to modulate tissue-specific splicing can involve targeting trans -acting splicing factors with small molecules. 26,100,109 Among the most promising developments are PROTACs and molecular glues, both of which promoting proteasome-mediated degradation of the target. 103,151 These drug agents can induce almost complete protein degradation even when present at substochiometric concentration with respect to the target splicing factor.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, splicing activators such as the splicing factor SRSF6 are known to be overexpressed in various cancers, correlating with poor prognostic outcomes. 100 Studies have demonstrated that SRSF6 promotes colorectal cancer (CRC) proliferation, migration, and invasion in vitro , as well as tumor development and metastasis in NOD/SCID mice. 101 SRSF6 contributes to tumorigenesis by modulating the alternative splicing of key tumor-associated genes, including ZO-1 exon 23, a critical cell adhesion molecule.…”
Section: Small Molecules Targeting Trans-splicing Factorsmentioning
confidence: 99%
“…hnRNPs possess one or two RNA recognition motif (RRM) domains, alongside unstructured domains that enable them to regulate their interactions with other proteins (Krecic & Swanson, 1999). Similarly, SR proteins feature RNA recognition motif domains at their amino terminus, allowing for RNA‐binding specificity, and a carboxy‐terminal arginine/serine‐rich (RS) domain that impacts their interactions with other proteins (Li et al, 2023; Long & Caceres, 2009). Both families of splicing factors undergo post‐translational modifications, which play a crucial role in governing their cellular localization, RNA binding affinity, and protein–protein interactions (Galganski et al, 2017).…”
Section: Pre‐mrna Splicingmentioning
confidence: 99%